Fmoc-N-(2,4,6-trimethoxybenzyl)-glycine, 97%, 1g

2,3,3a,4,7,7a-hexahydro-1H-isoindole, 95.0%, 5g

(S)-3-(3-acetyl-4-hydroxyphenyl)-2-aminopropanoic acid hydrochloride, 98%, 100mg

N-(6-Hydrazinyl-6-oxohexyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 97%, 1g

1H-Indeno[5,4-f]quinoline-7-carboxylic acid, hexadecahydro-1,4a,6a-triMethyl-2-oxo-, Methyl ester, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-, 98%, 250mg

(E)-ETHYL 3-(1-METHYL-1H-PYRAZOL-4-YL)ACRYLATE, 95.0%, 10g

Methyl 2-(5-(trifluoromethyl)pyridin-2-yl)acetate, 97.0%, 5g

4-Methyl-2-methylenepentanoic acid, 95%, 100mg

N-Methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide, 95.0%, 100g

2-Bromoacetamide, 95.0%, 100g

Chroman-4-carboxylic acid, 95.0%, 50mg

(3-(1H-NAPHTHO[1,8-DE][1,3,2]DIAZABORININ-2(3H)-YL)PHENYL)BORONIC ACID PINACOL ESTER, 95.0%, 1g

(1-(3-Methoxyphenyl)cyclobutyl)methanamine, 95+%, 5g